Cargando…

Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings

Infectious disease nucleic acid amplification technologies (NAAT) have superior sensitivity, specificity, and rapid time to result compared to traditional microbiological methods. Recovery of concentrated, high quality pathogen nucleic acid (NA) from complex specimen matrices is required for optimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Beall, Shivani G., Cantera, Jason, Diaz, Maureen H., Winchell, Jonas M., Lillis, Lorraine, White, Heather, Kalnoky, Michael, Gallarda, James, Boyle, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472818/
https://www.ncbi.nlm.nih.gov/pubmed/30998749
http://dx.doi.org/10.1371/journal.pone.0215753
_version_ 1783412318000906240
author Beall, Shivani G.
Cantera, Jason
Diaz, Maureen H.
Winchell, Jonas M.
Lillis, Lorraine
White, Heather
Kalnoky, Michael
Gallarda, James
Boyle, David S.
author_facet Beall, Shivani G.
Cantera, Jason
Diaz, Maureen H.
Winchell, Jonas M.
Lillis, Lorraine
White, Heather
Kalnoky, Michael
Gallarda, James
Boyle, David S.
author_sort Beall, Shivani G.
collection PubMed
description Infectious disease nucleic acid amplification technologies (NAAT) have superior sensitivity, specificity, and rapid time to result compared to traditional microbiological methods. Recovery of concentrated, high quality pathogen nucleic acid (NA) from complex specimen matrices is required for optimal performance of several NA amplification/detection technologies such as polymerase chain reaction (PCR). Fully integrated NAAT platforms that enable rapid sample-to-result workflows with minimal user input are generally restricted to larger reference lab settings, and their complexity and cost are prohibitive to widespread implementation in resource limited settings (RLS). Identification of component technologies for incorporation of reliable and affordable sample preparation with pathogen NA amplification/detection into an integrated platform suitable for RLS, is a necessary first step toward achieving the overarching goal of reducing infectious disease-associated morbidity and mortality globally. In the current study, we evaluate the performance of six novel NA extraction technologies from different developers using blinded panels of stool, sputum and blood spiked with variable amounts of quality-controlled DNA- and/or RNA-based microbes. The extraction efficiencies were semi-quantitatively assessed using validated real-time reverse transcription (RT)-PCR assays specific for each microbe and comparing target-specific RT-PCR results to those obtained with reference NA extraction methods. The technologies were ranked based on overall diagnostic accuracy (analytical sensitivity and specificity). Sample input and output volumes, total processing time, user-required manual steps and cost estimates were also examined for suitability in RLS. Together with the performance analysis, these metrics were used to select the more suitable candidate technologies for further optimization of integrated NA amplification and detection technologies for RLS.
format Online
Article
Text
id pubmed-6472818
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-64728182019-05-03 Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings Beall, Shivani G. Cantera, Jason Diaz, Maureen H. Winchell, Jonas M. Lillis, Lorraine White, Heather Kalnoky, Michael Gallarda, James Boyle, David S. PLoS One Research Article Infectious disease nucleic acid amplification technologies (NAAT) have superior sensitivity, specificity, and rapid time to result compared to traditional microbiological methods. Recovery of concentrated, high quality pathogen nucleic acid (NA) from complex specimen matrices is required for optimal performance of several NA amplification/detection technologies such as polymerase chain reaction (PCR). Fully integrated NAAT platforms that enable rapid sample-to-result workflows with minimal user input are generally restricted to larger reference lab settings, and their complexity and cost are prohibitive to widespread implementation in resource limited settings (RLS). Identification of component technologies for incorporation of reliable and affordable sample preparation with pathogen NA amplification/detection into an integrated platform suitable for RLS, is a necessary first step toward achieving the overarching goal of reducing infectious disease-associated morbidity and mortality globally. In the current study, we evaluate the performance of six novel NA extraction technologies from different developers using blinded panels of stool, sputum and blood spiked with variable amounts of quality-controlled DNA- and/or RNA-based microbes. The extraction efficiencies were semi-quantitatively assessed using validated real-time reverse transcription (RT)-PCR assays specific for each microbe and comparing target-specific RT-PCR results to those obtained with reference NA extraction methods. The technologies were ranked based on overall diagnostic accuracy (analytical sensitivity and specificity). Sample input and output volumes, total processing time, user-required manual steps and cost estimates were also examined for suitability in RLS. Together with the performance analysis, these metrics were used to select the more suitable candidate technologies for further optimization of integrated NA amplification and detection technologies for RLS. Public Library of Science 2019-04-18 /pmc/articles/PMC6472818/ /pubmed/30998749 http://dx.doi.org/10.1371/journal.pone.0215753 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Beall, Shivani G.
Cantera, Jason
Diaz, Maureen H.
Winchell, Jonas M.
Lillis, Lorraine
White, Heather
Kalnoky, Michael
Gallarda, James
Boyle, David S.
Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings
title Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings
title_full Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings
title_fullStr Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings
title_full_unstemmed Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings
title_short Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings
title_sort performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472818/
https://www.ncbi.nlm.nih.gov/pubmed/30998749
http://dx.doi.org/10.1371/journal.pone.0215753
work_keys_str_mv AT beallshivanig performanceandworkflowassessmentofsixnucleicacidextractiontechnologiesforuseinresourcelimitedsettings
AT canterajason performanceandworkflowassessmentofsixnucleicacidextractiontechnologiesforuseinresourcelimitedsettings
AT diazmaureenh performanceandworkflowassessmentofsixnucleicacidextractiontechnologiesforuseinresourcelimitedsettings
AT winchelljonasm performanceandworkflowassessmentofsixnucleicacidextractiontechnologiesforuseinresourcelimitedsettings
AT lillislorraine performanceandworkflowassessmentofsixnucleicacidextractiontechnologiesforuseinresourcelimitedsettings
AT whiteheather performanceandworkflowassessmentofsixnucleicacidextractiontechnologiesforuseinresourcelimitedsettings
AT kalnokymichael performanceandworkflowassessmentofsixnucleicacidextractiontechnologiesforuseinresourcelimitedsettings
AT gallardajames performanceandworkflowassessmentofsixnucleicacidextractiontechnologiesforuseinresourcelimitedsettings
AT boyledavids performanceandworkflowassessmentofsixnucleicacidextractiontechnologiesforuseinresourcelimitedsettings